Abstract
Thiazole ring is an important active molecular skeleton of drugs. Thiazole in natural products and drugs are usually harmlessly eliminated. However, hepatotoxic reactions may occur due to the biological activation of thiazole to produce reactive thioamide. A typical example is hepatotoxic sudoxicam and safety meloxicam. The only structural difference between them is a methyl group on C5 position of thiazole in meloxicam. The molecular basis for the difference remains unknown and the bioactivation mechanism of the thiazole ring is still obscure. Quantum chemical calculations were performed to elucidate the activation mechanism of the thiazole ring under P450 catalysis, and the influence of the substituents on the activation pathways of thiazole ring was also studied. The calculated results show that the activation of thiazole is closely related to the substituents on the thiazole and spin state of Cpd I. The thiazole and substituted thiazole directly open the ring when catalyzed by doublet spin state Cpd I that catalyzed by the quartet spin state Cpd I can open the ring directly or indirectly, which is related to the substituents. Thiazoles modified with electron-donating substituents mainly undergo direct ring opening, while thiazoles modified with electron-withdrawing groups or weak electron-donating groups mainly undergo indirect ring-opening process accompanied by intermediate formation. The research results laid the foundation for the design of thiazole ring drugs, and also laid a theoretical foundation for the study of reducing the toxicity of thiazole ring drugs.
Similar content being viewed by others
Data availability
All the relevant research data are provided in the Supporting information.
References
Ayati A, Emami S, Asadipour A, Shafiee A, Foroumadi A (2015) Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery. Eur. J. Med. Chem. 97:699–718. https://doi.org/10.1016/j.ejmech.2015.04.015
de Siqueira LRP, de Moraes Gomes PAT, de Lima Ferreira LP, de Melo Rêgo MJB, Leite ACL (2019) Multi-target compounds acting in cancer progression: focus on thiosemicarbazone, thiazole and thiazolidinone analogues. Eur. J. Med. Chem. 170:237–260. https://doi.org/10.1016/j.ejmech.2019.03.024
Das J, Chen P, Norris D, Padmanabha R, Lin J, Moquin RV, Shen Z, Cook LS, Doweyko AM, Pitt S, Pang S, Shen DR, Fang Q, de Fex HF, McIntyre KW, Shuster DJ, Gillooly KM, Behnia K, Schieven GL, Wityak J, Barrish JC (2006) 2-Aminothiazole as a novel kinase inhibitor template. Structure−activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor. J. Med. Chem. 49 (23):6819–6832. doi:https://doi.org/10.1021/jm060727j
Walmsley S, Bernstein B, King M, Arribas J, Beall G, Ruane P, Johnson M, Johnson D, Lalonde R, Japour A, Brun S, Sun E (2002) Lopinavir–ritonavir versus nelfinavir for the initial treatment of HIV infection. N. Engl. J. Med. 346(26):2039–2046. https://doi.org/10.1056/NEJMoa012354
Pasqualotto AC, Thiele K, Goldani L (2010) Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole. Curr. Opin. Investig. Drugs 11(2):165–174
Fox LM, Saravolatz LD (2005) Nitazoxanide: a new thiazolide antiparasitic agent. Clin. Infect. Dis. 40(8):1173–1180. https://doi.org/10.1086/428839
Obach RS, Kalgutkar AS, Ryder TF, Walker GS (2008) In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam. Chem. Res. Toxicol. 21:1890. https://doi.org/10.1021/tx800185b
Maienfisch P, Angst M, Brandl F, Fischer W, Hofer D, Kayser H, Kobel W, Rindlisbacher A, Senn R, Steinemann A, Widmer H (2001) Chemistry and biology of thiamethoxam: a second generation neonicotinoid. Pest Manag. Sci. 57(10):906–913. https://doi.org/10.1002/ps.365
Vitaku E, Smith DT, Njardarson JT (2014) Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J. Med. Chem. 57(24):10257–10274. https://doi.org/10.1021/jm501100b
Dalvie DK, Kalgutkar AS, Khojasteh-Bakht SC, Obach RS, O’Donnell JP (2002) Biotransformation reactions of five-membered aromatic heterocyclic rings. Chem. Res. Toxicol. 15(3):269–299. https://doi.org/10.1021/tx015574b
Hobbs DC, Twomey TM (1977) Metabolism of sudoxicam by the rat, dog, and monkey. Drug Metabolism and Disposition 5 (1):75 doi:10.1.1.1070.5457
Roth SH (2001) Arthritis therapy: a better time, a better day. Rheumatology 40(6):603–606. https://doi.org/10.1093/rheumatology/40.6.603
Schmid J, Busch U, Trummlitz G, Prox A, Kaschke S, Wachsmuth H (1995) Meloxicam: metabolic profile and biotransformation products in the rat. Xenobiotica 25(11):1219–1236. https://doi.org/10.3109/00498259509046678
Uetrecht J, Naisbitt DJ (2013) Idiosyncratic adverse drug reactions: current concepts. Pharmacol. Rev. 65(2):779. https://doi.org/10.1124/pr.113.007450
Barnette DA, Schleiff MA, Osborn LR, Flynn N, Matlock M, Swamidass SJ, Miller GP (2020) Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam. Toxicology 440:152478. https://doi.org/10.1016/j.tox.2020.152478
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M (2018) DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 46 (D1):D1074-D1082. doi:https://doi.org/10.1093/nar/gkx1037
Shaik S, Hirao H, Kumar D (2007) Reactivity patterns of cytochrome P450 enzymes: multifunctionality of the active species, and the two states-two oxidants conundrum. Nat. Prod. Rep. 24(3):533–552. https://doi.org/10.1039/B604192M
Li C, Wu W, Cho K-B, Shaik S (2009) Oxidation of tertiary amines by cytochrome P450—kinetic isotope effect as a spin-state reactivity probe. Chemistry – A European Journal 15 (34):8492–8503. doi:doi:https://doi.org/10.1002/chem.200802215
Taxak N, Desai PV, Patel B, Mohutsky M, Klimkowski VJ, Gombar V, Bharatam PV (2012) Metabolic-intermediate complex formation with cytochrome P450: theoretical studies in elucidating the reaction pathway for the generation of reactive nitroso intermediate. J. Comput. Chem. 33(21):1740–1747. https://doi.org/10.1002/jcc.23008
Li X-X, Wang Y, Zheng Q-C, Zhang H-X (2016) Detoxification of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by cytochrome P450 enzymes: a theoretical investigation. J. Inorg. Biochem. 154(154):21–28. https://doi.org/10.1016/j.jinorgbio.2015.10.009
Özkılıç Y, Tüzün NŞ (2019) Mechanism of kynurenine 3-monooxygenase-catalyzed hydroxylation reaction: a quantum cluster approach. J. Phys. Chem. A 123(14):3149–3159. https://doi.org/10.1021/acs.jpca.8b11831
Sono M, Roach MP, Coulter ED, Dawson JH (1996) Heme-containing oxygenases. Chem. Rev. 96(7):2841–2888. https://doi.org/10.1021/cr9500500
Shaik S, Cohen S, Wang Y, Chen H, Kumar D, Thiel W (2010) P450 enzymes: their structure, reactivity, and selectivity—modeled by QM/MM calculations. Chem. Rev. 110(2):949–1017. https://doi.org/10.1021/cr900121s
Woolf TF, Radulovic LL (1989) Oxicams: metabolic disposition in man and animals. Drug Metab. Rev. 21(2):255–276. https://doi.org/10.3109/03602538909029942
Mizutani T, Yoshida K, Kawazoe S (1994) Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products. Drug Metabolism and Disposition 22 (5):750 doi:https://doi.org/10.1080/004982598239704
Chesne C, Guyomard C, Guillouzo A, Schmid J, Ludwig E, Sauter T (1998) Metabolism of Meloxicam in human liver involves cytochromes P4502C9 and 3A4. Xenobiotica 28(1):1–13. https://doi.org/10.1080/004982598239704
Funding
This work is based on research supported by the Meritocracy Research Funds of China West Normal University (17YC037).
Author information
Authors and Affiliations
Contributions
Xue Bai performed the theoretical calculation and wrote the article, Lijun Yang interpreted the results and modified the article, and Dan Qin did the proof reading.
Corresponding author
Ethics declarations
Consent to participate
All the authors give their consent.
Consent for publication
All the authors give their consent.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 112 kb)
Rights and permissions
About this article
Cite this article
Bai, X., Qin, D. & Yang, L. Importance of substituents in ring opening: a DFT study on a model reaction of thiazole to thioamide. J Mol Model 27, 89 (2021). https://doi.org/10.1007/s00894-021-04704-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00894-021-04704-5